Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
The trial has five separate groups. People may be considered for one of the following groups:
Group I:
- People with a body mass index (BMI) between 18.5 and 25.0
- People who have a type of ovulation problem classified as "Group 1" by the World Health Organization
- People with low or normal levels of certain reproductive hormones (FSH and LH) and low estrogen levels
- People who do more than 5 hours per week of moderate to vigorous exercise and have low energy intake relative to their body composition
- People who have had other causes of their ovulation problems ruled out
- People who have signed an informed consent form
Group II:
- People diagnosed with Polycystic Ovary Syndrome (PCOS) of a specific type (phenotype I, II, or III by NIH-2012 guidelines) that includes high levels of male hormones
- People with a BMI between 18.5 and 40.0
- People who have signed an informed consent form
Group III:
- People diagnosed with a specific type of PCOS (phenotype IV by NIH-2012 guidelines)
- People with a BMI between 18.5 and 40.0
- People who have signed an informed consent form
Group IV:
- People with a BMI between 18.5 and 25.0
- People who have regular menstrual periods
- People with normal reproductive hormone levels during the first part of their menstrual cycle
- People who do more than 5 hours per week of moderate to vigorous exercise and eat enough to support their body composition
- People who have signed an informed consent form
Group V:
- People with no signs or symptoms of high male hormone levels
- People who do no exercise or only light physical activity
- People who have regular menstrual periods
- People with a BMI between 18.5 and 40.0
- People who have signed an informed consent form
Who may not be able to join:
- People who have taken certain medications in the past 6 months that can affect ovulation, including steroids, antipsychotics, antidepressants, contraceptives, hormones, or opioids
- People who are currently pregnant or breastfeeding, or who have been pregnant or breastfeeding in the past 6 months
- People who have a uterine condition called Asherman's syndrome or other structural problems affecting the reproductive tract
- People who currently smoke or drink more than 40g of alcohol per day
- People who have a previous diagnosis of blood sugar problems, high blood pressure, abnormal cholesterol, heart or lung disease, kidney disease, liver disease, coeliac disease, any condition affecting nutrient absorption, chronic inflammatory disease, or cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Héctor F Escobar-Morreale, PhD, MD, Diabetes, Obesity and Human Reproduction Research Group (CIBERDEM), Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
Phone: 34913369029
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adipokine and myokine signaling identification
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.